-
FDA Approves Bristol-Myers’ Leukemia Drug May 27, 2009
Posted in Xcelerated Profits Report.
No comments
© 2010 Mt. Vernon Research LLC
105 West Monument Street, Baltimore, MD 21201
Mt Vernon Research LLC does not act as an investment advisor or advocate the purchase or sale of any security or investment. Mt Vernon Research LLC expressly forbids its writers from having a financial interest in any security recommended to its readers. All of our employees and agents must wait 24 hours after an Internet publication prior to following an initial recommendation. And for hard-copy-only publications, 72 hours after the publication is mailed. Investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. White Cap Research provides its members with unique opportunities to build and protect wealth under all market conditions. The executive staff, research department and editors who contribute to White Cap Research’s recommendations are proud of the reputation that we have built. We believe the advice presented to its members in our published resources and at our meetings and seminars is the best and most useful available to investors today.
The recommendations and analysis presented to members is for the exclusive use of members. Copying or disseminating any information published by Mt Vernon Research LLC and/or White Cap Research, electronic or otherwise is strictly prohibited. Members should be aware that investment markets have inherent risks and there can be no guarantee of future profits. Likewise, past performance does not assure future results. Recommendations are subject to change at any time.